Comparative in vitro activity of a new quinolone, fleroxacin, against respiratory pathogens from patients with cystic fibrosis.

Gelijkaardige items

• In vitro activity of tosufloxacin, a new quinolone, against respiratory pathogens derived from cystic fibrosis sputum.
  door: Arguedas, A G, et al.
  Gepubliceerd in: (1990)
• In vitro activity of E-1040, a 3-substituted cephalosporin, against pathogens from cystic fibrosis sputum.
  door: Stutman, H R, et al.
  Gepubliceerd in: (1990)
• In vitro activity of sparfloxacin (AT-4140), a new quinolone agent, against invasive isolates from pediatric patients.
  door: Akaniro, J C, et al.
  Gepubliceerd in: (1992)
• In vitro activities of 4-quinolones against the fish pathogen Aeromonas salmonicida.
  door: Barnes, A C, et al.
  Gepubliceerd in: (1990)
• In Vitro Activities of β-Lactam–β-Lactamase Inhibitor Antimicrobial Agents against Cystic Fibrosis Respiratory Pathogens
  door: Caverly, Lindsay J., et al.
  Gepubliceerd in: (2019)